✦ LIBER ✦

Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

✍ Scribed by Cascinu, Stefano; Berardi, Rossana; Sobrero, Alberto; Bidoli, Paolo; Labianca, Roberto; Siena, Salvatore; Ferrari, Daris; Barni, Sandro; Aitini, Enrico; Zagonel, Vittorina; Caprioni, Francesco; Villa, Federica; Mosconi, Stefania; Faloppi, Luca; Tonini, Giuseppe; Boni, Corrado; Conte, Pierfranco; Di Costanzo, Francesco; Cinquini, Michela

Book ID: 122091075
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 737 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2013.09.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escalated Radiation Dose Without Chemoth

Escalated Radiation Dose Without Chemotherapy Does Not Improve Resectability for Locally Advanced Unresectable Rectal Cancer Over Standard Chemoradiation: Results of a Phase II Randomized Study

✍ Engineer, R.; Mohandas, K.; Shukla, P.; Shrikhande, S.; Goel, M.; Chopra, S.; Sh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Intensive weekly chemotherapy is not eff

Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

✍ Cascinu, S; Frontini, L; Comella, G; Barni, S; Labianca, R; Battelli, N; Casaret 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

A phase I/II, non-randomized, feasibilit

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

✍ Sil Kordes, Dick J. Richel, Heinz-Josef Klümpen, Mariëtte J. Weterman, Arnoldus 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 181 KB

Addition of AEG35156 XIAP Antisense Olig

Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study

✍ Aaron D. Schimmer; Wolfgang Herr; Mathias Hänel; Gautham Borthakur; Arthur Frank 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 329 KB

Randomized phase II – study evaluating E

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

✍ R Krempien; MW Muenter; PE Huber; S Nill; H Friess; C Timke; B Didinger; P Buech 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 321 KB

284 Does effective chemotherapy for meta

284 Does effective chemotherapy for metastatic colorectal cancer (CC) improve quality of life (QL)? Preliminary results of a randomized phase II-study using the eortc QLQ C30

✍ P. Schöffski; C.-H. Köhne; U. Schellenberger; U. Schubert; H. Wilke; C. Käufer; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 165 KB